SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-025020
Filing Date
2024-08-07
Accepted
2024-08-07 08:05:16
Documents
15
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20240522_8k.htm   iXBRL 8-K 30812
2 EXHIBIT 99.1 ex_678272.htm EX-99.1 189418
  Complete submission text file 0001437749-24-025020.txt   387764

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clnn-20240807.xsd EX-101.SCH 3942
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20240807_def.xml EX-101.DEF 13520
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20240807_lab.xml EX-101.LAB 17825
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20240807_pre.xml EX-101.PRE 13497
17 EXTRACTED XBRL INSTANCE DOCUMENT clnn20240522_8k_htm.xml XML 4965
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 241181525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)